Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort.
Yee N, Markovic D, Buhr RG, Fortis S, Arjomandi M, Couper D, Anderson WH, Paine R 3rd, Woodruff PG, Han MK, Martinez FJ, Barr RG, Wells JM, Ortega VE, Hoffman EA, Kim V, Drummond MB, Bowler RP, Curtis JL, Cooper CB, Tashkin DP, Barjaktarevic IZ.
Yee N, et al.
Chest. 2022 Apr;161(4):949-959. doi: 10.1016/j.chest.2021.10.046. Epub 2021 Nov 10.
Chest. 2022.
PMID: 34767825
Free PMC article.
STUDY DESIGN AND METHODS: The study included 832 current and former smokers with post-bronchodilator FEV(1)/FVC 0.7 from the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) cohort. Participants were classified as having a reduced pre-bronchodi …
STUDY DESIGN AND METHODS: The study included 832 current and former smokers with post-bronchodilator FEV(1)/FVC 0.7 from the Subpopulations …